
H1N1 Vaccine Global Market Report 2025 Including: 1) By Product Type: Inactivated Vaccine; Live Attenuated Vaccine 2) By Route Of Administration: Intradermal Vaccination; Intramuscular Vaccination; Subcutaneous Vaccination 3) By End Users: Hospitals; Cl
Description
H1N1 Vaccine Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on h1n1 vaccine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Where is the largest and fastest growing market for h1n1 vaccine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The h1n1 vaccine market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Markets Covered:1) By Product Type: Inactivated Vaccine; Live Attenuated Vaccine
2) By Route Of Administration: Intradermal Vaccination; Intramuscular Vaccination; Subcutaneous Vaccination
3) By End Users: Hospitals; Clinics; Research And Diagnostic Laboratories; Other End Users
Subsegments:
1) By Inactivated Vaccine: Injectable Inactivated Vaccine; Intranasal Inactivated Vaccine
2) By Live Attenuated Vaccine: Injectable Live Attenuated Vaccine; Intranasal Live Attenuated Vaccine
Companies Mentioned: Sanofi SA; GlaxoSmithKline PLC; CSL Limited; AstraZeneca Inc.; Zydus Lifesciences Limited
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
This report focuses on h1n1 vaccine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for h1n1 vaccine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The h1n1 vaccine market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Product Type: Inactivated Vaccine; Live Attenuated Vaccine
2) By Route Of Administration: Intradermal Vaccination; Intramuscular Vaccination; Subcutaneous Vaccination
3) By End Users: Hospitals; Clinics; Research And Diagnostic Laboratories; Other End Users
Subsegments:
1) By Inactivated Vaccine: Injectable Inactivated Vaccine; Intranasal Inactivated Vaccine
2) By Live Attenuated Vaccine: Injectable Live Attenuated Vaccine; Intranasal Live Attenuated Vaccine
Companies Mentioned: Sanofi SA; GlaxoSmithKline PLC; CSL Limited; AstraZeneca Inc.; Zydus Lifesciences Limited
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Table of Contents
200 Pages
- 1. Executive Summary
- 2. H1N1 Vaccine Market Characteristics
- 3. H1N1 Vaccine Market Trends And Strategies
- 4. H1N1 Vaccine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
- 5. Global H1N1 Vaccine Growth Analysis And Strategic Analysis Framework
- 5.1. Global H1N1 Vaccine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global H1N1 Vaccine Market Growth Rate Analysis
- 5.4. Global H1N1 Vaccine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global H1N1 Vaccine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global H1N1 Vaccine Total Addressable Market (TAM)
- 6. H1N1 Vaccine Market Segmentation
- 6.1. Global H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Inactivated Vaccine
- Live Attenuated Vaccine
- 6.2. Global H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Intradermal Vaccination
- Intramuscular Vaccination
- Subcutaneous Vaccination
- 6.3. Global H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Clinics
- Research and Diagnostic Laboratories
- Other End Users
- 6.4. Global H1N1 Vaccine Market, Sub-Segmentation Of Inactivated Vaccine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Injectable Inactivated Vaccine
- Intranasal Inactivated Vaccine
- 6.5. Global H1N1 Vaccine Market, Sub-Segmentation Of Live Attenuated Vaccine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Injectable Live Attenuated Vaccine
- Intranasal Live Attenuated Vaccine
- 7. H1N1 Vaccine Market Regional And Country Analysis
- 7.1. Global H1N1 Vaccine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global H1N1 Vaccine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8. Asia-Pacific H1N1 Vaccine Market
- 8.1. Asia-Pacific H1N1 Vaccine Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 9. China H1N1 Vaccine Market
- 9.1. China H1N1 Vaccine Market Overview
- 9.2. China H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 10. India H1N1 Vaccine Market
- 10.1. India H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11. Japan H1N1 Vaccine Market
- 11.1. Japan H1N1 Vaccine Market Overview
- 11.2. Japan H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12. Australia H1N1 Vaccine Market
- 12.1. Australia H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13. Indonesia H1N1 Vaccine Market
- 13.1. Indonesia H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14. South Korea H1N1 Vaccine Market
- 14.1. South Korea H1N1 Vaccine Market Overview
- 14.2. South Korea H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15. Western Europe H1N1 Vaccine Market
- 15.1. Western Europe H1N1 Vaccine Market Overview
- 15.2. Western Europe H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16. UK H1N1 Vaccine Market
- 16.1. UK H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17. Germany H1N1 Vaccine Market
- 17.1. Germany H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18. France H1N1 Vaccine Market
- 18.1. France H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19. Italy H1N1 Vaccine Market
- 19.1. Italy H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20. Spain H1N1 Vaccine Market
- 20.1. Spain H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21. Eastern Europe H1N1 Vaccine Market
- 21.1. Eastern Europe H1N1 Vaccine Market Overview
- 21.2. Eastern Europe H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22. Russia H1N1 Vaccine Market
- 22.1. Russia H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23. North America H1N1 Vaccine Market
- 23.1. North America H1N1 Vaccine Market Overview
- 23.2. North America H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24. USA H1N1 Vaccine Market
- 24.1. USA H1N1 Vaccine Market Overview
- 24.2. USA H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25. Canada H1N1 Vaccine Market
- 25.1. Canada H1N1 Vaccine Market Overview
- 25.2. Canada H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26. South America H1N1 Vaccine Market
- 26.1. South America H1N1 Vaccine Market Overview
- 26.2. South America H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27. Brazil H1N1 Vaccine Market
- 27.1. Brazil H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28. Middle East H1N1 Vaccine Market
- 28.1. Middle East H1N1 Vaccine Market Overview
- 28.2. Middle East H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29. Africa H1N1 Vaccine Market
- 29.1. Africa H1N1 Vaccine Market Overview
- 29.2. Africa H1N1 Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa H1N1 Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa H1N1 Vaccine Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 30. H1N1 Vaccine Market Competitive Landscape And Company Profiles
- 30.1. H1N1 Vaccine Market Competitive Landscape
- 30.2. H1N1 Vaccine Market Company Profiles
- 30.2.1. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. GlaxoSmithKline PLC Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. CSL Limited Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. AstraZeneca Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Zydus Lifesciences Limited Overview, Products and Services, Strategy and Financial Analysis
- 31. H1N1 Vaccine Market Other Major And Innovative Companies
- 31.1. Merck and Co.Inc.
- 31.2. Novavax Inc.
- 31.3. Panacea Biotec Ltd.
- 31.4. Sinovac Biotech Ltd.
- 31.5. Green Cross Corp.
- 31.6. Pfizer Inc.
- 31.7. Seqirus Ltd.
- 31.8. Cipla Inc.
- 31.9. Protein Sciences Corporation
- 31.10. Hualan Biological Engineering Inc.
- 31.11. Changsheng Bio-Technology Co. Ltd.
- 31.12. Bharat Biotech International Limited
- 31.13. Serum Institute of India Pvt. Ltd.
- 31.14. Bio Farma Group
- 31.15. PT Kalbe Farma Tbk
- 32. Global H1N1 Vaccine Market Competitive Benchmarking And Dashboard
- 33. Key Mergers And Acquisitions In The H1N1 Vaccine Market
- 34. Recent Developments In The H1N1 Vaccine Market
- 35. H1N1 Vaccine Market High Potential Countries, Segments and Strategies
- 35.1 H1N1 Vaccine Market In 2029 - Countries Offering Most New Opportunities
- 35.2 H1N1 Vaccine Market In 2029 - Segments Offering Most New Opportunities
- 35.3 H1N1 Vaccine Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.